(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Capital Hilton

Oct 28, 2024 8:30 AM - Oct 30, 2024 12:40 PM

1001 16th Street NW, Washington, DC 20036-5794

DIA/FDA Oligonucleotide-Based Therapeutics Conference

CONTACT US
Send Email 1.888.257.6457

Back to Agenda

Oligonucleotide Safety Working Group (OSWG) – Open Meeting

Session Chair(s)

Jeffrey Foy, PHD

Jeffrey Foy, PHD

Executive Director, Toxicology, Nimbus Therapeutics, United States

Oligonucleotide Safety Working Group (OSWG) – Open Meeting

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.